Product description
Peroxisome proliferator-activated receptor y (PPARy) isoforms heterodimerize with retinoic X receptors to modulate gene expression related to adipocyte differentiation, fatty acid uptake and storage, and glucose metabolism.{18294} Natural agonists of PPARy include fatty acids (e.g., linoleic acid and 15-deoxy-d12,14-prostaglandin J2), while thiazolidinediones (e.g., rosiglitazone and pioglitazone) are potent synthetic agonists.{18295,18296} Fmoc-L-leucine is a partial agonist of PPARy.{18295,11781} It activates PPARy with a lower potency (Ki = 15 versus 0.035 µM) but a similar maximal efficacy compared to rosiglitazone.{11781} Fmoc-L-leucine improves insulin resistance in normal, diet-induced glucose-intolerant and in diabetic db/db mice, yet has reduced adipogenic activity.{11781} As a result, it is classified as a selective PPARy modulator (SPPARM), capable of producing insulin-sensitizing effects while minimizing side effects associated with full agonists.{18295}
Specifications
CAS number
35661-60-0
Supplier
Cayman Chemical
Shipping & storage
Shipping condition
Room Temperature
Storage temperature
20-25°C

Order your product by email

Productname

Fmoc-L-Leucine

10004888-50

By filling out this form, you are placing an order by e-mail. You will receive an order confirmation within one working day. The order cannot be modified after receipt of the order confirmation.


Request a sample

Productname

Fmoc-L-Leucine

10004888-50

By filling out this form, you request a sample. You will receive an order confirmation within one working day. The order cannot be modified after receipt of the order confirmation.


Organization information

*Required fields


Are you looking for specific products, alternatives or documentation?